Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yep! I was here too and it had my head spinning! LOL It's actually amazing how long many of us have been here.
How are you coming up with September for the 25M? Those shares were given out for services prior to June M/E 2017. Whoever got those shares, are going to have a hard time getting the restrictions lifted to sell. The 144 rule can not be used on shell companies. The OTC has this flagged as a shell company. They might be able to use the Section 4(a)(1) rule, but that's only after they hold the stock for 2 years. Both the SEC and OTC have been cracking down on the illegal dumping of restricted stock, so an attorney is going to think twice about writing an opinion letter for the TA. Brokers have also been put on notice about excepting stock under these circumstances too.
Just for the record, it was not Berney who hijacked this shell. It was E.G. Marchi (with the help of attorney Morey). It happened back in 2012, It was Barton who stepped in and put a stop to it. He actually saved the shareholders, because Marchi was trying to do a 1 to 300 R/S and playing games with the preferred stock. With Dustin's help, Barton was able to get the OTC filings and the Nevada Corp filings cancelled. That took some time. Look at the OTC disclosures under the "inactive" link and the history in the Nevada Corp details.
Maybe the N/A answers are due to the fact they are on the Pink Limited Information Tier. They aren't required to include info. They do recognize the issuance of shares in their financial reports.
Right from that disclosure form:
"A company in the Limited Information tier, may, but is not required to, include information in accordance with these OTC Pink Basic Disclosure Guidelines using the fillable form beginning on page 3."
They went dark in 2005 because the number of shareholders didn't require SEC filings. They submitted the appropriate form to the SEC at that time.
If a company takes over the shell, I doubt seriously Barton or Garcia will stick around, so it doesn't matter their history.
According to the filing, they are splitting the Authorized at the same time, so there won't be many shares for a new company to issue. At least not without making another change to up the authorized. That actually had me scratching my head, because most companies that do a R/S, only do it on the issued shares and leave the Authorized unchanged (which allows them to dump millions of shares).
That's nonsense. The only one wanting the price to go down is you.
Those state licenses are important to the future plans, although they already started filling scripts in Texas and NY (2017 10k).
Great day and just getting started!
Companies on the "OTC Pink - Limited Information Tier" aren't required to have attorney letters. They're only required to have limited financial information not older than six months. Info/requirements (with links) below.
LIMITED INFORMATION (Yield Sign)
Designed for companies with financial reporting problems, economic distress, or in bankruptcy, that make the limited information they have publicly available. Companies in this category have limited financial information not older than six months available on www.otcmarkets.com or on the SEC's EDGAR system.
https://www.otcmarkets.com/corporate-services/information-for-pink-companies
Qualifications for the OTC Pink - Limited Information Tier
Companies that make the information described below publicly available within the prior 6 months qualify for the OTC Pink Limited Information.
Subscribe to the OTC Disclosure & News Service on www.OTCIQ.com to publish financial reports and material news.
Create a Quarterly Report or Annual Report for a fiscal period ended within the previous 6 months, save it in PDF format and upload it via www.OTCIQ.com. The Quarterly Report or Annual Report includes:
Balance Sheet
Income Statement
Total Number of Issued and Outstanding Shares
Financial statements must be prepared in accordance with US GAAP, but are not required to be audited. (Please note that Cash Flow Statements are not required to qualify for OTC Pink Limited Information; however, unless the financial statements include a Cash Flow Statement, no financial data will be included in the OTC Financials Data Service via EDGAR Online, which distributes company financial data to online investor portals and makes the data available on the Financials tab on the company’s quote page on www.otcmarkets.com.
A company on OTC Pink Limited Information, may, but is not required to, include information in accordance with the OTC Pink Basic Disclosure Guidelines.
https://www.otcmarkets.com/files/OTCPinkGuidelines.docx
Too funny... someone sold 738 shares at .0055 for a grand total of $4.06! Someone really wants to scare people!
The 10Q should be due today (for March month end). If they file a late notice, it will be due next Tuesday. Love the action today!
Peter Berney is dead Bleu.
CBD getting some positive attention today!
FDA panel unanimously backs GW Pharma's cannabis-based epilepsy drug
(Reuters) - GW Pharmaceuticals Plc’s cannabis-derived drug to treat a severe form of childhood epilepsy was unanimously backed on Thursday by an advisory panel to the U.S. Food and Drug Administration.
The 13-to-0 vote sets the stage for the approval of the first-ever cannabis-derived treatment in the United States.
The panel’s backing was widely expected, after FDA staff on Tuesday gave a favorable review citing findings from three clinical studies that showed the drug reduced frequency of seizures in patients with the disease when added to a current therapy.
The FDA does not have to act on the recommendations of its experts, but typically does.
A potential approval of the drug, Epidiolex, a final decision on which is due by June 27, would confirm the therapeutic benefits of cannabidiol (CBD) - an active ingredient found in marijuana from which the drug is derived.
Epidiolex is designed to treat Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS), rare childhood-onset forms of epilepsy that are among the most resistant to treatment.
“There is little evidence that CBD has meaningful abuse potential,” an FDA staffer said during the meeting.
https://www.reuters.com/article/us-gw-fda/fda-panel-unanimously-backs-gw-pharmas-cannabis-based-epilepsy-drug-idUSKBN1HQ2CG
They released this PR Tuesday and 8k yesterday with details.
LAS VEGAS, NV -- April 17, 2018 -- InvestorsHub NewsWire -- Freedom Leaf Inc. (OTCQB: FRLF), a group of diversified, international, vertically-integrated hemp business and cannabis media companies, consummated its previously-announced acquisition of the Irie CBD Product Line, including virtually all: assets, trademarks, formulating equipment, formulas and products.
Irie is a California-based CBD, “Cannabidiol”, product line that, and has been operating since 2015, it formulates, manufactures and distributes CBD tinctures, CBD edibles, CBD topicals and CBD concentrates to retail markets across the country. Irie boasts a large inventory of more than 25 different products and recorded approximately $1.5 million of revenue in 2017and net profits in excess of $200,000. Irie also leases a full manufacturing and processing facility in Oakland, California.
In addition to the Irie CBD line and associated assets and trademarks, the acquisition also includes: the product lines, websites and other assets of: Earth Born, Inc., a California corporation; Earth Born, Inc., a Delaware corporation; Irie Living, a California nonprofit mutual benefit corporation, and Genesis Media Works, LLC, a Utah limited liability company doing business as “Terra’s Way,” “Irie Hemp Company,” and “Earth Born Botanicals.”
Clifford Perry, CEO and Co-Founder of Freedom Leaf, commented: “The acquisition of the Irie CBD product lines adds another level of integration to our already vertically-integrated business model – increasing our revenues and margins. Freedom Leaf already has commenced providing Irie CBD with the raw material from our Leafceuticals extractions. Going forward we will produce our exclusive Hempology full spectrum hemp CBD line utilizing Irie’s existing processing facilities.” Perry explained further: “In addition to the revenue generation and processing capabilities resulting from this acquisition, Freedom Leaf hopes to be able to utilize the established name of Irie CBD to market the Hempology CBD.”
Freedom Leaf paid $356,080 in cash and approximately 8,118,886 shares of the Company’s common stock (valued at $1.844 million). The transaction provided for possible purchase price reductions based on the acquisition achieving targeted post-closing monthly revenue targets.
Richard Groberg, Chief Financial Officer for Freedom Leaf, also explained: “Completing the Irie CBD acquisition is directly in line with Freedom Leaf’s goal of creating a more financially stable corporation in the cannabis/hemp space. Freedom Leaf expects to see a direct growth in sales for the target’s existing product lines as well as providing various cost-saving and revenue-enhancing aspects to Freedom Leaf’s existing businesses.” Groberg went on to say: “While we plan to retain the targets key executives, at least through a transition period, the application of the years of experience of Freedom Leaf’s team to the Irie CBD team should be invaluable in growing their revenues.”
The acquisition of Irie CBD adds to Freedom Leaf’s current portfolio of cannabis/hemp media and processing companies, including: their flagship publication Freedom Leaf Magazine; one of the largest Spanish-speaking web portal in the world LaMarihuana.com; the exclusive high-quality Hempology CBD product line; its extraction and distribution division Leafceuticals Inc, and its European hemp cultivation and production company Green Market Europe. The acquired assets include the following web sites: www.iriecbd.com, www.iriejournal.com, www.iriemedicinals.com, www.irieliving.org, www.iriehemp.com, www.earthbornbotanicals,com, www.terrasway.com, www.pranahemp
What a closing! Fun to watch.
We should be close to hearing something about the Irie acquisition. April 15th was the anticipated closing date.
I'm glad I added more earlier this week. Chart looking good.. next week should be fun!
Yesterday (Wednesday) was the 13th day. We won't know if they covered untiI later tonight. I hope so, I think they will stop trying to hold price down once they cover their "fails to deliver".
Here's the link to the Finra page where you can pull up the number of days they have been on the list.. Put the symbol in on the left of table and change start date to 03/01/18. In addition, the quote I posted about covering, can be found on the top of the page.
http://otce.finra.org/RegSHO#
As of Friday, RXMD had been on the SHO threshold list for 10 consecutive settlement days. Here's what the rules say regarding when the MMs have to cover their "fails to delivery".
"Pursuant to Rule 203(b)(3) of Regulation SHO and FINRA Rule 4320, a participant of a registered clearing agency (i.e., a clearing firm), that has a fail to deliver position at a registered clearing agency (i.e., National Securities Clearing Corporation) in a Threshold Security for 13 consecutive settlement days must immediately close out that fail to deliver position by purchasing shares of like kind and quantity."
Yeah, these dips can be brutal at times, but I look at them as buying opportunities. I was able to add more shares in the 12s today.
It was the MMs that were short. RXMD was tagged with the Reg SHO threshold flag this week. They've shown up on the short list on and off, but this is the first time I've seen them on the Reg Sho report. Hopefully they were able to buy enough shares to cover their "fails to deliver" and will let us move up!
https://www.otcmarkets.com/market-activity/reg-sho-data
I would be careful about calling someone a liar. I'm on the eTrade app and it still shows the .0211. I missed the half hour of trading and just now had a chance to log on (6:45 CST). I about had a stroke when I looked at my portfolio. I realized it had to be a mistake when I saw it happened after hours. The quote page still shows it as the last trade though! LOL
UPDATE: The Wall Street Investor Forum 26th Annual Investor Conference
12:23 PM ET 3/22/18 | GlobeNewswire
UPDATE: The Wall Street Investor Forum 26th Annual Investor Conference
MIAMI, March 22, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announced today that due to weather conditions, the Company was not able to attend the conference as planned.
The Company will be preparing a video presentation for shareholders and investors that will be posted on the Company's website next week.
"We are disappointed that we were not able to make it to the conference being held today," stated S. Parikh Mars, CEO. "We hope that everyone in the northeast is safe and that we can get our presentation out to our shareholders and investors soon."
I'm sure it will be in the video. It's a good stand alone presentation, but will be even better with accompanying commentary. I'm glad investors at the forum, still have access to charts. It gives them a chance to look over data and hopefully, get any questions they may have to company before video is made.
Even though they weren't able to give presentation live, their charts are posted on the webcast link. Here's the link.
http://www.investorcalendar.com/console/26495
RXMD is current with their filings. Their Fiscal Year ends Dec 31st, so a 10K is due instead of a 4th quarter 10Q. The 10K is due the end of March.
Awesome close and great day!
You people just crack me up. I see you bought shares this week , in a company with a market cap of over 76M. That company has yet to show any revenue! If you wanted to take profit or short, fine, but at least be honest about it!
"doing very well- if we pop .20 =>kaboom"
Not "if", but "when we pop .20". No doubt it's going to happen! Cheers!
I wasn't afraid! Haha I've averaged up twice this week (buying the dips)! I'm a trader by nature, but this company has impressed me and is so rare in this world! I'm not going anywhere!
I've been here for a few years and I know it's a very big risk, but the odds are looking better! LOL. I'll tell you what has made me do a lot of speculating lately... that's the law group they listed on their new website.
Cook is their securities lawyer, so it begs the question, why they listed the Austin Group in San Diego on their new website. I googled Gina Austin and marijuana. She not only represents several marijuana companies, she has spoken at several MJ seminars in California about how to legally raise funding for their businesses. You can find her speaking in a couple of YouTube videos. She also has a securities attorney in her firm who specializes in mergers. It's pure speculation on my part! I could be barking up the wrong tree, but man, it's fun to dream!Good luck!
I need to correct myself! I said PPLC, it's actually PLLC! Sorry about that!
I think Barton messed up the name of Christian's firm. I think the AG actually stands for "Accurum Group" and instead of PLC it should be PPLC. Here's the info in AIMH filing. Notice Christian's email address. If you google Accurum Group you will find them and they have the same PO Box.
Accountant or Auditor
Name: CHRISTIAN CARNELL, CPA
Firm: AG GROUP, PLC
Address 1: PO BOX 1842
Address 2: BOUNTIFUL, UT 84011
Phone: (801) 573-4719
Email: CHRISTIAN@ACCURUMGROUP.COM
You and I have the same perspective here. I've been doing some digging and I think the missing key here is Doug Bowes and his Bioworx Pharmacy/lab. I've always believed Bioworx is the lab we use in Florida. And of course, Bowes has been working with us and is listed as one of the "brains" on Rising Biosciences web site. Under experience on his LinkedIn profile,
he shows advisor to Rising Biosciences in Cleveland/Akron.
Anyway, I found Bioworx already has a "non-resident-category 3" license in Ohio (link below). Issued through Ohio's Pharmacy State Board. Category 3 is what's issued to distributors of dangerous drugs.
https://license.ohio.gov/Lookup/SearchDetail.asp?ContactIdnt=4482207&DivisionIdnt=96&Type=L
Yeah, I'm not the least bit worried about trademark. I posted that, because some seem to question the use of "TM", when they hadn't registered. It's a non-problem! LOL
Trademark (™)
"TM is used to signify common-law rights in a trademark pursuant to the Lanham Act. Thus, those who have not yet registered their brand name with the United States Patent and Trademark Office (USPTO) should list a ™ instead of a R. The same goes for those applications submitted but not yet accepted. TM is typically used to protect an unregistered mark by alerting potential infringers that a term, slogan, logo or other indicator is being claimed as a trademark. However, the use of TM does not guarantee the owner’s mark will be protected under trademark law. To succeed in a common-law infringement action under the Lanham Act, the trademark owner must prove: 1) s/he was the first to use the trademark and 2) the infringing party’s use of the trademark confuses the public from distinguishing the goods’ source."
Freedom Leaf, Inc. Is Eliminating Its Toxic Convertible Securities; Management Focused on Generating Multiple Revenue Streams
Source: InvestorsHub NewsWire
Freedom Leaf, Inc. Is Eliminating Its Toxic Convertible Securities; Management Focused on Generating Multiple Revenue Streams
Freedom Leaf, Inc. does not handle, grow, sell, or dispense marijuana; our European activities are in full compliance with relevant EU laws
LAS VEGAS, NV -- January 04, 2018 -- InvestorsHub NewsWire -- Freedom Leaf, Inc. (OTCQB: FRLF), The Marijuana Legalization Company®, a group of diversified, international, vertically-integrated Cannabis/Hemp businesses and media companies, announced yesterday the continuation of retiring outstanding convertible debt. On December 15, 2017, a convertible note of $38,000 was retired through a payment made to the lender. Currently, Freedom Leaf, Inc. has 3 other convertible notes on our books that we intend to retire prior to their 6-month anniversaries just as we did with the aforementioned convertible note.
Clifford Perry, CEO, stated, "We are committed to a program of enhancing shareholder value by focusing on generating revenue with our merchandising projects derived from our wholly owned subsidiary Leafceuticals, Inc, and eliminating toxic convertible securities that could dilute shareholder value. Currently, our Hempology products, Vapes, CBD Oil and CBD Dog Treats are available at MyHempology.com Also in conjunction with Reliable Steel and Harris Farms, Ltd, a licensed Nevada Hemp grower, Leafceuticals, Inc is using the NuAxon Supercritical CO2 Extractor to process the hemp flower and we plan on using the extracted oil in our product line, as well as selling CBD Oil to manufacturers."
About Freedom Leaf
Freedom Leaf, Inc., The Marijuana Legalization Company®, is a fully reporting and audited, publicly traded company trading under the symbol (OTCQB:FRLF). Freedom Leaf, Inc. is a leading go-to resource in the cannabis, medical marijuana, and industrial hemp industry. It is involved in mergers and acquisitions and business consulting in the marijuana industry, including incubation/acceleration and spin offs of new marijuana/hemp related companies.
Freedom Leaf, Inc.'s flagship publication is Freedom Leaf Magazine, "The Good News in Marijuana Reform." The company produces a portfolio of news, print and digital multi-media verticals, websites, blogs and web advertising, for the ever-changing emerging cannabis, medical marijuana and industrial hemp industry.
Freedom Leaf, Inc. does not handle, grow, sell, or dispense marijuana. All of our European activities are in full compliance with relevant EU laws.
Corporate Website and Investor Relations: http://www.FreedomLeafInc.com
Safe Harbor Statement
Statements in this press release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements, including any financial projections above, generally can be identified by phrases such as Freedom Leaf, Inc. or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" "projections" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Factors that could cause or contribute to differences include the uncertainty regarding viability and market acceptance of the Company's products and services, changes in relationships with third parties, and other factors described in the Company's most recent periodic filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K dated June 30, 2017 and quarterly reports on Form 10-Q.
CONTACT INFORMATION: Raymond MedeirosPR and Business Development Director
Phone: 415-601-1974
Email: Ray@FreedomLeaf.com
Freedom Leaf, Inc.
3571 East Sunset Road
Las Vegas, NV 89120
Terms and Conditions
DELIVERY TIME
Delivery times are typically toward the end of the subscription month/beginning of the following month, depending upon location. Dates commence from the date of shipping, rather than the date of order. Delivery times are to be used as a guide only and are subject to the acceptance and approval of your order. Unless there are exceptional circumstances, we make every effort to fulfill all orders on the same day every month. Business day means Monday to Friday. Please note we do not ship on weekends or holidays. Date of delivery may vary due to carrier shipping practices, delivery location, method of delivery, and the items ordered.
http://zwagbox.com/terms_conditions